Annual Report

Overview

The report describes Antengene's 2024 progress in expanding access to XPOVIO®, including a new indication approved in Mainland China. It reports 9 ongoing clinical studies across China, the United States and Australia, covering 9 pipeline assets. The ESG disclosures report total Scope 1 and 2 GHG emissions of 994.47 tonnes of CO2e for the year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services